Company Filing History:
Years Active: 2025
Title: Innovations of Mary Michael Brody
Introduction
Mary Michael Brody is a notable inventor based in Menlo Park, California. She has made significant contributions to the field of immunology, particularly in the expansion of T-cell populations. Her work is characterized by a focus on innovative methods that can potentially lead to advancements in medical treatments.
Latest Patents
Mary Michael Brody holds a patent for "Methods for selective expansion of delta-3 gamma delta T-cell populations and compositions thereof." This patent is directed to agents that bind an epitope specific to a δ3 γδ TCR. The agents can include antibodies or fragments thereof. The patent also describes methods for using these agents to expand or selectively expand δ3 γδ T cells, which can be utilized for treating subjects in need.
Career Highlights
Mary is currently associated with Adicet Therapeutics, Inc., where she continues to work on innovative solutions in the field of immunotherapy. Her research has the potential to impact the treatment of various diseases by harnessing the power of T-cells.
Collaborations
Mary has collaborated with notable professionals in her field, including Aya Jakobovits and Daulet Kadyl Satpayev. These collaborations enhance the research and development efforts at Adicet Therapeutics, Inc.
Conclusion
Mary Michael Brody's contributions to the field of immunology through her innovative patent and work at Adicet Therapeutics, Inc. highlight her role as a significant inventor. Her research may pave the way for new therapeutic approaches in medicine.